-
公开(公告)号:EP2139487B1
公开(公告)日:2015-11-11
申请号:EP08744513.6
申请日:2008-03-27
申请人: Pharmacyclics LLC
发明人: HONIGBERG, Lee , VERNER, Erik , BUGGY, Joseph, J. , LOURY, David , CHEN, Wei
IPC分类号: A61K31/52 , A61P29/00 , A61P35/00 , A61K31/519 , C07D253/06 , C07D487/04 , C07D473/34
CPC分类号: C07D487/04 , A61K31/52 , C07D471/04 , C12Q1/485 , G01N33/57426 , G01N2440/14 , G01N2500/00
-
2.
公开(公告)号:EP3311818A2
公开(公告)日:2018-04-25
申请号:EP17191704.0
申请日:2009-07-16
申请人: Pharmacyclics, LLC
发明人: HONIGBERG, Lee , VERNER, Erik , BUGGY, Joseph , LOURY, David , CHEN, Wei
IPC分类号: A61K31/52 , A61P35/00 , A61K31/519 , A61K31/00 , A61K31/675 , A61K31/704 , A61K33/24 , A61K31/19 , A61K31/337
CPC分类号: A61K31/519 , A61K31/00 , A61K31/337 , A61K31/52 , A61K31/675 , A61K31/704 , A61K33/24 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2300/00 , A61K31/19
摘要: Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
摘要翻译: 本文描述了不可逆的Btk抑制剂化合物,以及使用此类不可逆抑制剂治疗以实体瘤的存在或发展为特征的疾病和病症的方法。
-
公开(公告)号:EP2307025B1
公开(公告)日:2017-09-20
申请号:EP09798770.5
申请日:2009-07-16
申请人: Pharmacyclics LLC
发明人: HONIGBERG, Lee , VERNER, Erik , BUGGY, Joseph , LOURY, David , CHEN, Wei
IPC分类号: A61K31/52 , A61P35/00 , A61K31/519 , A61K31/00
CPC分类号: A61K31/519 , A61K31/00 , A61K31/337 , A61K31/52 , A61K31/675 , A61K31/704 , A61K33/24 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2300/00 , A61K31/19
摘要: Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
-
公开(公告)号:EP3311818A3
公开(公告)日:2018-07-18
申请号:EP17191704.0
申请日:2009-07-16
申请人: Pharmacyclics, LLC
发明人: HONIGBERG, Lee , VERNER, Erik , BUGGY, Joseph , LOURY, David , CHEN, Wei
IPC分类号: A61K31/52 , A61P35/00 , A61K31/519 , A61K31/00 , A61K31/675 , A61K31/704 , A61K33/24 , A61K31/19 , A61K31/337
CPC分类号: A61K31/519 , A61K31/00 , A61K31/337 , A61K31/52 , A61K31/675 , A61K31/704 , A61K33/24 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2300/00 , A61K31/19
摘要: Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
-
-
-